Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | XIAP | P98170 | 1/20 | 0.52 |
| ▸ | DPP4 | P27487 | 4/20 | 0.51 |
| ▸ | DPP7 | Q9UHL4 | 4/20 | 0.51 |
| ▸ | DPP8 | Q6V1X1 | 4/20 | 0.51 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.51 |
| ▸ | FAP | Q12884 | 1/20 | 0.51 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.46 |
| ▸ | NTSR2 | O95665 | 4/20 | 0.45 |
| ▸ | NTSR1 | P30989 | 4/20 | 0.45 |
| ▸ | SORT1 | Q99523 | 4/20 | 0.45 |
| ▸ | ITGB3 | P05106 | 2/20 | 0.44 |
| ▸ | ITGA2B | P08514 | 2/20 | 0.44 |
| ▸ | F2 | P00734 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16701230 | 1.00 | XIAP (0.52) | XIAPDPP4DPP7DPP8DPP9 | |
| SCHEMBL20740209 | 1.00 | XIAP (0.52) | XIAPDPP4DPP7DPP8DPP9 | |
| SCHEMBL16702238 | 1.00 | XIAP (0.52) | XIAPDPP4DPP7DPP8DPP9 | |
| SCHEMBL16702590 | 1.00 | XIAP (0.52) | XIAPDPP4DPP7DPP8DPP9 | |
| SCHEMBL16701255 | 1.00 | XIAP (0.52) | XIAPDPP4DPP7DPP8DPP9 | |
| SCHEMBL29350414 | 0.93 | XIAP (0.56) | XIAPDPP4DPP7DPP8DPP9 | |
| SCHEMBL31206270 | 0.90 | XIAP (0.66) | XIAPDPP4DPP7DPP8DPP9 | |
| SCHEMBL29801899 | 0.88 | DPP4 (0.54) | XIAPDPP4DPP7DPP8DPP9 | |
| SCHEMBL29530800 | 0.87 | XIAP (0.54) | XIAPDPP4DPP7DPP8DPP9 | |
| SCHEMBL30490609 | 0.86 | DPP4 (0.50) | XIAPDPP4DPP7DPP8DPP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10383911-B2 | Storage stable lyophilized tripeptide formulations | DR. AUGUST WOLFF GMBH & CO. KG ARZNEIMITTEL (DE) | 2019-08-20 | — | — | US | disclosed |
| US-10383911-B2 | Storage stable lyophilized tripeptide formulations | DR. AUGUST WOLFF GMBH & CO. KG ARZNEIMITTEL (DE) | 2019-08-20 | — | — | US | disclosed |
| EP-3065756-B1 | STORAGE STABLE LYOPHILIZED TRIPEPTIDE FORMULATIONS | DR AUGUST WOLFF GMBH & CO KG ARZNEIMITTEL (DE) | 2019-02-20 | — | — | EP | disclosed |
| US-20160279188-A1 | STORAGE STABLE LYOPHILIZED TRIPEPTIDE FORMULATIONS | DR. AUGUST WOLFF GMBH & CO. KG ARZNEIMITTEL (DE) | 2016-09-29 | — | — | US | disclosed |
| US-20160279188-A1 | STORAGE STABLE LYOPHILIZED TRIPEPTIDE FORMULATIONS | DR. AUGUST WOLFF GMBH & CO. KG ARZNEIMITTEL (DE) | 2016-09-29 | — | — | US | disclosed |
| EP-3065756-A1 | STORAGE STABLE LYOPHILIZED TRIPEPTIDE FORMULATIONS | Dr. August Wolff GmbH & Co. KG Arzneimittel (DE) | 2016-09-14 | — | — | EP | disclosed |
| CN-105744945-A | Storage stable lyophilized tripeptide formulations | 奥古斯特沃尔夫博士有限两合公司-医药 | 2016-07-06 | — | — | CN | disclosed |
| WO-2015067493-A1 | STORAGE STABLE LYOPHILIZED TRIPEPTIDE FORMULATIONS | DR. AUGUST WOLFF GMBH & CO. KG ARZNEIMITTEL (DE) | 2015-05-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160279188-A1 | STORAGE STABLE LYOPHILIZED TRIPEPTIDE FORMULATIONS | PTMS, ITCH, PREP | XIAP 194/4885DPP4 1047/4885DPP7 1239/4885 |
| US-10383911-B2 | Storage stable lyophilized tripeptide formulations | PTMS, ITCH, PREP | XIAP 194/4885DPP4 1047/4885DPP7 1239/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.